Enter assignee name

Trademarks = 8

Forward Citations = 1

Loading Chart...

5 inventors (with patents filed for the assignee):

Frank Wu (3 out of 13 patents)

Lin Li (2 out of 4 patents)

Rongyao Chen (2 out of 2 patents)

4. Zhonghui Wan (2 out of 2 patents)

5. Zejuan Sheng (1 out of 1 patent)

6 patents: Sort by Forward Citations

1. 12465601 - Uses of phosphodiesterase inhibitors (2025-11-11),

2. 12371432 - Haloallylamine compounds and application thereof (2025-07-29),

3. 12291534 - Aminonorbornane derivative and manufacture method therefor and use thereof (2025-05-06),

4. 12234233 - Crystal form of phosphodiesterase inhibitor, preparation method therefor and use thereof (2025-02-25),

5. 11718620 - Method for treating a cancer mediated by abnormality of multi-kinases (2023-08-08),

6. 11420975 - Substituted imidazo[1,5-a]pyrazines as Bruton's tyrosine kinase inhibitors (2022-08-23),

Transthera Sciences (Nanjing), Inc. is a biopharmaceutical company focused on developing innovative therapies for unmet medical needs. The company specializes in the research and development of novel drug candidates targeting various diseases, leveraging advanced technologies and scientific expertise. With a commitment to improving patient outcomes, Transthera aims to bring transformative treatments to market through rigorous clinical trials and collaborations with healthcare professionals.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 30 2025

6 Patents

#100 in Jiangsu

#3,913 in China

Jiangsu, China

Transthera Sciences (nanjing), Inc.